Kura Oncology Up Over 13%, on Pace for Largest Percent Increase Since January 2024 -- Data Talk

Dow Jones
Aug 15

Kura Oncology, Inc. (KURA) is currently at $7.48, up $0.88 or 13.33%

 

--Would be highest close since March 24, 2025, when it closed at $7.65

--On pace for largest percent increase since Jan. 24, 2024, when it rose 46.13%

--Currently up four consecutive days; up 35.02% over this period

--Longest winning streak since June 6, 2025, when it rose for five straight trading days

--Best four day stretch since the four days ending Jan. 29, 2024, when it rose 38.6%

--Up 35.02% this week; best weekly performance since the week ending Sept. 8, 2017, when it rose 66.20%

--Up 23.64% month-to-date

--Down 14.12% year-to-date

--Down 82.03% from its all-time closing high of $41.62 on Dec. 11, 2020

--Down 61.14% from 52 weeks ago (Aug. 16, 2024), when it closed at $19.25

--Down 64.52% from its 52-week closing high of $21.08 on Sept. 19, 2024

--Up 35.02% from its 52-week closing low of $5.54 on Aug. 11, 2025

--Traded as high as $7.59; highest intraday level since March 25, 2025, when it hit $7.73

--Up 15% at today's intraday high; largest intraday percent increase since Jan. 30, 2024, when it rose as much as 23.23%

 

All data as of 10:49:20 AM ET

 

Source: Dow Jones Market Data, FactSet

 

(END) Dow Jones Newswires

August 15, 2025 10:52 ET (14:52 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10